{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:29:08Z","timestamp":1792726148812,"version":"4.5.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,4]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Isolation of BOECs from multiple patients with VWD is feasible, and the study of BOECs helps explain the pathogenic complexity of VWD. Abnormalities in WPB biogenesis and exocytosis and defects in VWF string formation correlate with the phenotypic features of patients with VWD.<\/jats:p>","DOI":"10.1182\/blood-2012-06-434373","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T02:21:51Z","timestamp":1361413311000},"page":"2762-2772","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":79,"title":["Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease"],"prefix":"10.1182","volume":"121","author":[{"given":"Jiong-Wei","family":"Wang","sequence":"first","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"},{"name":"Laboratory of Experimental Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline A. M.","family":"Bouwens","sequence":"additional","affiliation":[{"name":"Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands;"},{"name":"Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina","family":"Pintao","sequence":"additional","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Voorberg","sequence":"additional","affiliation":[{"name":"Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands;"},{"name":"Sanquin-Academic Medical Center Landsteiner Laboratory, Amsterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Safdar","sequence":"additional","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine M.","family":"Valentijn","sequence":"additional","affiliation":[{"name":"Department of Molecular Cell Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty C.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Plasma Proteins, Sanquin Research, Amsterdam, The Netherlands;"},{"name":"Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter H.","family":"Reitsma","sequence":"additional","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Eikenboom","sequence":"additional","affiliation":[{"name":"Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"10","key":"2019111808510092100_B1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"19","key":"2019111808510092100_B2","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1182\/blood-2010-09-267492","article-title":"Functional architecture of Weibel-Palade bodies.","volume":"117","author":"Valentijn","year":"2011","journal-title":"Blood"},{"key":"2019111808510092100_B3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor.","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"2019111808510092100_B4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor.","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"issue":"4","key":"2019111808510092100_B5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells.","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111808510092100_B6","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","article-title":"ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.","volume":"100","author":"Dong","year":"2002","journal-title":"Blood"},{"issue":"3","key":"2019111808510092100_B7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1055\/s-0037-1619048","article-title":"Von Willebrand disease and Weibel-Palade bodies.","volume":"30","author":"Wang","year":"2010","journal-title":"Hamostaseologie"},{"key":"2019111808510092100_B8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1538-7836.2009.03367.x","article-title":"Genotype\/phenotype association in von Willebrand disease: is the glass half full or empty?","volume":"7","author":"Lillicrap","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3","key":"2019111808510092100_B9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease.","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"issue":"4","key":"2019111808510092100_B10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1084-9521(02)00061-7","article-title":"Biogenesis of Weibel-Palade bodies.","volume":"13","author":"Hannah","year":"2002","journal-title":"Semin Cell Dev Biol"},{"issue":"27","key":"2019111808510092100_B11","doi-asserted-by":"crossref","first-page":"24180","DOI":"10.1074\/jbc.M110.215194","article-title":"Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"issue":"7","key":"2019111808510092100_B12","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2003-02-0599","article-title":"Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.","volume":"102","author":"Michaux","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019111808510092100_B13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1538-7836.2009.03290.x","article-title":"Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage.","volume":"7","author":"Haberichter","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111808510092100_B14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0309-1651(84)90067-5","article-title":"Use of monoclonal antibody and colloidal gold in E.M. localization of von Willebrand factor in megakaryocytes and platelets.","volume":"8","author":"Jeanneau","year":"1984","journal-title":"Cell Biol Int Rep"},{"issue":"22","key":"2019111808510092100_B15","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1182\/blood-2009-09-244327","article-title":"The mutation N528S in the von Willebrand factor (VWF) propeptide causes defective multimerization and storage of VWF.","volume":"115","author":"Haberichter","year":"2010","journal-title":"Blood"},{"issue":"9","key":"2019111808510092100_B16","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/j.1538-7836.2010.03971.x","article-title":"Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.","volume":"8","author":"Castaman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111808510092100_B17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1538-7836.2009.03551.x","article-title":"An assessment of the pathogenic significance of the R924Q von Willebrand factor substitution.","volume":"7","author":"Berber","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2019111808510092100_B18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1182\/blood.V58.4.788.bloodjournal584788","article-title":"Characterization and properties of cultured human von Willebrand umbilical vein endothelial cells.","volume":"58","author":"Booyse","year":"1981","journal-title":"Blood"},{"issue":"7","key":"2019111808510092100_B19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V75.7.1466.1466","article-title":"Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage, and release in endothelial cells derived from patients with type I von Willebrand disease.","volume":"75","author":"Ewenstein","year":"1990","journal-title":"Blood"},{"issue":"1","key":"2019111808510092100_B20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1993.tb04636.x","article-title":"Type I von Willebrand disease, subtype \u2018platelet low\u2019: decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.","volume":"83","author":"Federici","year":"1993","journal-title":"Br J Haematol"},{"issue":"18","key":"2019111808510092100_B21","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1073\/pnas.84.18.6550","article-title":"Expression of abnormal von Willebrand factor by endothelial cells from a patient with type IIA von Willebrand disease.","volume":"84","author":"Levene","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019111808510092100_B22","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1073\/pnas.86.10.3793","article-title":"von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.","volume":"86","author":"de Groot","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111808510092100_B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI8071","article-title":"Origins of circulating endothelial cells and endothelial outgrowth from blood.","volume":"105","author":"Lin","year":"2000","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111808510092100_B24","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","article-title":"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.","volume":"104","author":"Ingram","year":"2004","journal-title":"Blood"},{"issue":"22","key":"2019111808510092100_B25","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1182\/blood-2011-05-355354","article-title":"Factor VIII alters tubular organization and functional properties of von Willebrand factor stored in Weibel-Palade bodies.","volume":"118","author":"Bouwens","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2019111808510092100_B26","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/01.ATV.0000069847.72001.E8","article-title":"Real-time imaging of the dynamics and secretory behavior of Weibel-Palade bodies.","volume":"23","author":"Romani de Wit","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2019111808510092100_B27","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans.","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"issue":"2","key":"2019111808510092100_B28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues.","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111808510092100_B29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111808510092100_B30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD).","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"7","key":"2019111808510092100_B31","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1537-2995.2005.00180.x","article-title":"Toward closed-system culture of blood origin endothelial cells.","volume":"45","author":"Wagner","year":"2005","journal-title":"Transfusion"},{"issue":"18","key":"2019111808510092100_B32","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1182\/blood-2010-02-266338","article-title":"NAADP links histamine H1 receptors to secretion of von Willebrand factor in human endothelial cells.","volume":"117","author":"Esposito","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111808510092100_B33","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1538-7836.2006.02273.x","article-title":"von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.","volume":"4","author":"Nossent","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2019111808510092100_B34","first-page":"37","article-title":"Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.","volume":"80","author":"de Romeuf","year":"1998","journal-title":"Thromb Haemost"},{"issue":"10","key":"2019111808510092100_B35","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2012.04891.x","article-title":"Formation of platelet-binding von Willebrand factor strings on non-endothelial cells.","volume":"10","author":"Wang","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111808510092100_B36","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111808510092100_B37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP.","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111808510092100_B38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1538-7836.2003.00190.x","article-title":"Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP).","volume":"1","author":"Kaufmann","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019111808510092100_B39","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V98.10.2973","article-title":"Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins.","volume":"98","author":"Bod\u00f3","year":"2001","journal-title":"Blood"},{"issue":"7","key":"2019111808510092100_B40","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1538-7836.2004.00732.x","article-title":"A novel type 2A (Group II) von Willebrand disease mutation (L1503Q) associated with loss of the highest molecular weight von Willebrand factor multimers.","volume":"2","author":"O\u2019Brien","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2019111808510092100_B41","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor.","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"issue":"6","key":"2019111808510092100_B42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3324\/haematol.2011.057216","article-title":"Biogenesis of Weibel-Palade bodies in von Willebrand\u2019s disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.","volume":"97","author":"Wang","year":"2012","journal-title":"Haematologica"},{"issue":"2","key":"2019111808510092100_B43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1006\/bbrc.2000.4139","article-title":"Endoplasmic reticulum retention and prolonged association of a von Willebrand\u2019s disease-causing von Willebrand factor variant with ERp57 and calnexin.","volume":"280","author":"Allen","year":"2001","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2762\/1365537\/2762.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/14\/2762\/1365537\/2762.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T09:57:58Z","timestamp":1574071078000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/14\/2762\/31148\/Analysis-of-the-storage-and-secretion-of-von"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":43,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-434373","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}